According to the report by Pienta et al., both OVOL1/2 serve as negative regulators in prostate or breast cancer, in which overexpression of OVOL1 or OVOL2 can decrease ZEB1 to restrict cells EMT, consequently suppressing metastasis [225]. The gene discussed is ZEB1; the disease is breast carcinoma.